Company page

Nextgen Biomed Ltd

Nextgen Biomed Ltd, trading under the ticker NXGN-M, is a public company based in Israel with a market capitalization of approximately $2.89 million. The company focuses on developing innovative biomedical solutions. As a publicly listed entity, it operates within the regulatory framework of the Israeli market.

profileNXGN-M:TASEAI content: aiUpdated June 24, 2026/company/nextgen-biomed-ltd/c-sdslbuar
Nextgen Biomed Ltd logo
Ticker
NXGN-M:TASE
Asset type
Stock
Market cap
$2.9M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TASE
Currency
ILA